Our Respiratory Trials

New GSK Asthma Study- Evaluating an experimental inhaler propellant

A Phase 3 study investigating the efficacy and long-term safety of the experimental, modified inhaler with a climate friendly propellant HFA-152a in comparison to the currently approved inhaler with propellant HFA-134a in participants aged 18 years and over with diagnosed asthma.

This study is only being conducted at our Central Coast site

Apply Now
Placeholder Image

Sanofi RSV/hMPV/PIV3 Vaccine Study

Phase 1 study to Investigate the Safety and Immunogenicity of a Combined Respiratory Syncytial Virus/human Metapneumovirus/Parainfluenza Virus type 3 investigational mRNA Vaccine Candidate in Adult Participants Aged 60 Years and Older.

This study is being conducted at our Central Coast, Brisbane and Western Sydney sites.

Apply Now
Placeholder Image

RSV/hMPV Vaccine Study with Paratus

A Phase 1 study to investigate the safety and immunogenicity of an adjuvanted RSV/hMPV mRNA vaccine in adult participants aged 60 to 75 years.

This study is being conducted at our Brisbane site.

Apply Now
Placeholder Image
Apply for future trials.
Paratus Clinical is always in need of dedicated patients who would like to contribute to answering important research questions.
If you would like to be contacted about future research opportunities, please select 'Register Now' and submit your details.
You will be contacted by a recruitment specialist shortly.